Allergan, the world's largest maker of silicone gel implants, has announced they've reached full enrollment of the silicone breast implant follow up study group by the FDA when the devices were reintroduced for cosmetic use in 2006. This study involved registering patients undergoing breast augmentation going forward so as to better understand outcomes. We'll be watching data group for years going forward on reoperations, hardening, rupture rates, and other parameters.
We were proud to have our patients enroll in this important study since 2006 and have respect for Allergan's role in improving education of both surgeons and patients regarding proper selection and use of these devices.
Dr
Rob Oliver Jr.
Plastic Surgery Specialists PC of Birmingham
(205) 298-8660
No comments:
Post a Comment